Feb
22

Bush’s empty water bottles

You are wandering lost in the desert for several days without water, parched, your lips cracking, tongue swollen, eyes rattling around in your skull, desparate for an oasis. A man appears, and you think you are saved; he tells you he’s got just what you need, water. But instead of life-sustaining liquid he gives you empty water bottles and a coupon for free water, usable at a well that has yet to be drilled.
Your hopes dashed, you expire.
Pres. Bush’s health reform plan provides individuals with tax breaks to help them buy insurance that for many does not exist. Sort of like water in a desert.

Continue reading Bush’s empty water bottles


Feb
20

health care consumerism update

There hasn’t been much in the popular press about consumer-directed health care of late. What a relief. That doesn’t mean we can bury the idea, as economists and policy makers of a libertarian bent are going to keep returning to the “market as solution to all” mantra until we successfully implant a wooden cross in their cold small hearts.
And to some degree consumerism in health care is appropriate and warranted, and therefore part of the answer to the health care reform question.

Continue reading health care consumerism update


Feb
19

Fixing Bush’s health care plan

Bob Laszewski has found the solution to the Bush health care program’s reliance on the non-functioning individual health insurance market. The plan needs a model that addresses the problems of medical underwriting, denial of coverage, age band underwriting, risk selection, access and availability, and it’s called “Part D”!


Feb
19

Actiq – the off-label poster child

Actiq is a narcotic taken in lollypop form, a technique that gets the drug to the pain centers quickly. Developed for break-through cancer pain, evidence now suggests that only 10% of Actiq users have cancer.The high-powered narcotic has been the subject of several recent reports and a state attorney general investigation concerning off-label use.

Continue reading Actiq – the off-label poster child


Feb
14

Health care dollars – Who spends how much

OK, so I’ve been a little obsessed with the First Health-Concentra deal. Several clients will be directly affected by the merger, and their priorities are mine. But I’ve been ignoring the larger world, including a report published in Health Affairs (subscription required) that has far-reaching implications.
Two researchers at CMS analyzed data on the concentration of health care expenditures, (what percentage of patients spend what portion of total medical expenses) and noted a surprising trend.

Continue reading Health care dollars – Who spends how much


Feb
7

The Edwards Plan

I’ve been trying to find a summary of the Edwards plan unblemished by opinion/criticism/odds-making, and so far all I’ve found is the same article written several different ways, and no synopsis.
No wonder we’re having a tough time engaging in a substantitive debate.

Continue reading The Edwards Plan


Feb
5

my aching back

Controversy over treatment types, overly generous payments to physicians to endorse a product, lawsuits alleging faulty research, the FDA under fire for inadequate evaluation, fights over reimbursement for a new procedure, and confusion over the usefulness of a common and very expensive procedure.
If you want to know why the US health care system is so dysfunctional, I give you low back pain.

Continue reading my aching back